Scopolamine Patch, Extended Release
Product Images NDC 71335-3013

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 71335-3013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353013)

Each transdermal system contains 1.3 mg of scopolamine which is formulated to deliver approximately 1 mg over 3 days in vivo. The system also contains inactive components like crospovidone, isopropyl palmitate, light mineral oil, and polyethylene. The transdermal system must be stored upright at 20°C to 25°C and should be kept out of reach of children. It is essential to remove the system before undergoing an MRI procedure to avoid possible burns. The package insert provides information on use and prescribing details.*

FDA Label Image

Extended Label (Lbl713353013extendedlabel)

This text provides instructions for the dosage and administration of a transdermal system. It advises washing and drying hands before applying the system, using only one system at a time, not cutting the system, removing the clear plastic backing, applying the system to a hairless area behind one ear as directed in the prescription information, and washing hands with soap and water after application.*

FDA Label Image

Chemical Structure (Scopolamine 01)

FDA Label Image

Image (Scopolamine 02)

This text describes the different layers of a drug delivery system. It includes a backing membrane, drug layer, rate-controlling membrane, and contact layer. It also mentions a release liner for the product. Each layer serves a specific function in controlling the release of the drug.*

FDA Label Image

Figure 1 (Scopolamine 03)

This text appears to be a description of a disposable release liner with a metallic adhesive surface and a tan backing membrane. It also mentions an imprint of 'Scopolamine 1mg/3 days'. The text possibly refers to a medical or pharmaceutical product.*

FDA Label Image

Figure 2 (Scopolamine 04)

FDA Label Image

Figure 3 (Scopolamine 05)

FDA Label Image

Figure 4 (Scopolamine 06)

This is a tan-colored transdermal system with a metallic adhesive surface. It comes with a clear, disposable release liner. (Figure 4)*

FDA Label Image

Figure 5 (Scopolamine 07)

This is a tan-colored transdermal system that is imprinted with a design. Please refer to Figure 5 for more details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.